Amanote Research
Register
Sign In
Activating JAK2 Mutants Reveal Cytokine Receptor Coupling Differences That Impact Outcomes in Myeloproliferative Neoplasm
Leukemia
- United Kingdom
doi 10.1038/leu.2017.1
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
January 6, 2017
Authors
H Yao
Y Ma
Z Hong
L Zhao
S A Monaghan
M-C Hu
L J Huang
Publisher
Springer Science and Business Media LLC
Related search
The C Allele of JAK2 Rs4495487 Is an Additional Candidate Locus That Contributes to Myeloproliferative Neoplasm Predisposition in the Japanese Population
BMC Medical Genetics
Genetics
JAK2 Exon 12 Mutation in Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis: Not an Exclusive Mutation to Polycythaemia Vera
British Journal of Haematology
Hematology
JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms
PLoS ONE
Multidisciplinary
JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Coexistence of Myeloproliferative Neoplasm and Plasma-Cell Dyscrasia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
PLA2R1 Mediates Tumor Suppression by Activating JAK2
Cancer Research
Cancer Research
Oncology
Erythrocyte-Derived Microvesicles Induce Arterial Spasms in JAK2V617F Myeloproliferative Neoplasm
Journal of Clinical Investigation
Medicine
Systemic Notch Downregulation Promotes Kras G12D ‐induced Myeloproliferative Neoplasm
British Journal of Haematology
Hematology
AT1-receptor Blockers: Differences That Matter
Journal of Human Hypertension
Internal Medicine
